Abstract: An electromagnetic induction heating apparatus for heating an aerosol-forming article of an electronic cigarette includes: a power supply unit configured to supply DC power; a power amplifier including a switch unit comprising a pair of transistor switches having a differential structure and receiving DC power from the power supply unit, and a parallel-structured LC resonant network including a resonant inductor connected to an output terminal of the switch unit and electromagnetically inductively coupled with an inductor component of a heat-generating body for heating the aerosol-forming article of the electronic cigarette, and a resonant capacitor connected in parallel to the resonant inductor; and a driving unit configured to adjust a temperature of the heat-generating body by adjusting an operating frequency of the switch unit of the power amplifier to control an amount of current of the resonant inductor electromagnetically inductively coupled with the inductor component of the heat-generating body.

Abstract: Disclosed are various methods for transmitting or receiving data or control information having high reliability conditions. A method for operating a terminal which transmits uplink control information (UCI) includes: a step of generating UCI; a step of comparing the priority of an uplink (UL) control channel for the transmission of the UCI with the priority of a UL data channel when some symbols of the UL control channel and the UL data channel overlap; and a step of selecting the UL channel having a higher priority among the UL control channel and the UL data channel, and transmitting the UCI to a base station through the selected UL channel.

Abstract: The present invention relates to a composition for inhibiting angiogenesis, containing neo-N-methylsansalvamide (NMSSV), which is a cyclic pentadepsipeptide, as an effective ingredient, and specifically, since the NMSSV of the present invention has excellent activity which inhibits cell migration and tube formation associated with angiogenesis, and concentration-dependently inhibits angiogenesis induced by a vascular endothelial growth factor, it is expected that the NMSSV of the present invention may inhibit angiogenesis and be usefully used as a therapeutic agent for various diseases in which angiogenesis is abnormally regulated.

Abstract: The present invention relates to a composition for inhibiting angiogenesis, containing neo-N-methylsansalvamide (NMSSV), which is a cyclic pentadepsipeptide, as an effective ingredient, and specifically, since the NMSSV of the present invention has excellent activity which inhibits cell migration and tube formation associated with angiogenesis, and concentration-dependently inhibits angiogenesis induced by a vascular endothelial growth factor, it is expected that the NMSSV of the present invention may inhibit angiogenesis and be usefully used as a therapeutic agent for various diseases in which angiogenesis is abnormally regulated.